Is the Catapult share price cheap?

Catapult Group Ltd (ASX:CAT) has a mixed track record.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Catapult Group Ltd (ASX: CAT) share price is up 3% to $1.09 this morning and is now up around 66% since lows printed around 60 cents in early February 2019.

That might sound exciting until you consider the stock is actually down from a high of $4.05 in August 2016 to suggest that this is a business the market struggles to value.

The stock is up today after it announced that it has signed am "aggregated contract" with the Australian NRL to supply all its associated clubs and bodies.

"Catapult is executing a clear strategy to own the performance technology stack in elite sport, with a range oftechnology solutions that now include wearables, video analytics, and an athlete management platform," commented its chairman Adir Shiffman.

Catapult is notable as a software-as-a-service type business that trades on a low multiple of forecast sales or annual recurring revenue in particular compared to the sky high multiples of the likes of WiseTech Global Ltd (ASX: WTC) or Xero Limited (ASX: XRO).

Of course these are all totally different businesses and Catapult's management has chopped and changed over the last couple of years, while it raised capital at increasingly lower share prices. Hardly moves out of the MBA handbook on running a business and as such the market's confidence in the business is shaken.

I sold out of the shares just below $2 in August 2017 foreseeing the trouble ahead, however, I might return to the share register depending on its next quarterly update.

Tom Richardson owns shares of Xero. You can find Tom on Twitter @tommyr345 The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Catapult Group International Ltd. The Motley Fool Australia owns shares of WiseTech Global and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »